| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,520 | 0,575 | 12:46 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | ADICON HOLDINGS (09860): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 2 | HKEx | ||
| Di | ADICON HOLDINGS (09860): CHANGE OF NON-EXECUTIVE DIRECTORS AND CHANGE IN THE COMPOSITION OF BOARD COMMITTEE | - | HKEx | ||
| ADICON Aktie jetzt für 0€ handeln | |||||
| 13.02. | ADICON HOLDINGS (09860): APPOINTMENT OF EXECUTIVE DIRECTOR AND CHANGE IN THE COMPOSITION OF BOARD COMMITTEE | 1 | HKEx | ||
| 13.02. | ADICON HOLDINGS (09860): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 13.11.25 | Crown Bioscience Inc.: JSR Life Sciences unterzeichnet endgültige Vereinbarung zur Übertragung von Crown Bioscience an Adicon Holdings Limited | 490 | Business Wire | Strategische Transaktion positioniert Crown Bioscience für beschleunigtes Wachstum in der translationalen Onkologie
JSR Life Sciences LLC ("JSR Life Sciences"), ein weltweit führender Anbieter... ► Artikel lesen | |
| 13.11.25 | JSR Life Sciences to Transfer Crown Bioscience to Adicon Holdings Ltd. | 5 | Contract Pharma | ||
| 13.11.25 | EQS Newswire: Adicon Holdings Limited: Adicon to Acquire Crown Bioscience for US$204 Million, Creating a Global End-to-End Laboratory Service Platform | 460 | EQS Group (EN) | EQS Newswire / 13/11/2025 / 16:48 UTC+8
Hangzhou, China - Nov.13, 2025 - Adicon Holdings Limited ("Adicon", 9860.HK), a leading independent clinical laboratory service provider in China and a... ► Artikel lesen | |
| 13.11.25 | Crown Bioscience Inc.: JSR Life Sciences Enters Definitive Agreement to Transfer Crown Bioscience to Adicon Holdings Limited | 538 | Business Wire | Strategic Transaction Positions Crown Bioscience for Accelerated Growth in Translational Oncology
JSR Life Sciences LLC ("JSR Life Sciences"), a global leader in life sciences materials and services... ► Artikel lesen | |
| 13.11.25 | ADICON HOLDINGS (09860): MAJOR ACQUISITION - IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES OF THE TARGET COMPANY | 1 | HKEx | ||
| 04.09.25 | ADICON HOLDINGS (09860): 2025 INTERIM REPORT | 1 | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 19,220 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,560 | +0,87 % | Gewinnwarnung von FMC, Oerlikon mit Sonderdividende und Takkt muss Dividende streichen - BÖRSE TO GO | Fresenius Medical Care überraschte am Morgen mit einer Gewinnwarnung. Trotz des starken Gewinnsprungs im Vorjahr sieht man schwarz für 2026. Oerlikon kündigte nach dem Barmag Verkauf eine Sonderdividende... ► Artikel lesen | |
| FRESENIUS | 50,40 | -1,79 % | DAX-Check: BMW, Fresenius, Hochtief, MTU, Vonovia, Zalando | Donald Trump wirbelt die Märkte mal wieder durcheinander. Der US-Präsident kündigte neue globale Zölle an. Zuvor hatte der Supreme Court die bisherigen Zollmaßnahmen für unrechtmäßig erklärt. Die Unsicherheit... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,510 | -2,08 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,380 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 22,670 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 17,685 | 0,00 % | Truist cuts Progyny stock price target on covered lives miss | ||
| GERRESHEIMER | 16,760 | +6,75 % | Gerresheimers Abschluss unter dem Röntgenblick der BaFin | Die BaFin verschärft den Blick auf die Rechnungslegung der Gerresheimer AG. Sie kündigt an, die am 18.09.2025 gestartete Anlassprüfung des offengelegten Konzernabschlusses und Konzernlageberichts 2023/2024... ► Artikel lesen | |
| GENEDX | 79,77 | 0,00 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| CARL ZEISS MEDITEC | 26,480 | -2,93 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen | |
| ONEMEDNET | 1,030 | 0,00 % | OneMedNet-Aktie steigt nach Plattform-Launch um 90 % | ||
| PRIVIA HEALTH GROUP | 23,730 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| PACS GROUP | 36,475 | 0,00 % | Truist raises PACS Group stock price target to $50 on margin strength | ||
| ADAPTHEALTH | 9,155 | 0,00 % | Leerink cuts AdaptHealth stock price target on 2025 earnings decline | ||
| ESSILORLUXOTTICA | 222,10 | -1,29 % | FedEx, EssilorLuxottica sued by customers for tariff refunds |